Will Markets Crash Again? This Famous Investor Is Nervous

Investors are worried that another market crash will occur before the end of 2020. Ben Inker, the head of GMO’s Asset Allocation team, is scared.

Arrow descending on a graph

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

GMO Asset Management is one of the largest firms in the world when it comes to investing with a macro focus. Before the coronavirus crash, it managed more than $100 billion in assets.

You may be familiar with the company’s well-known co-founder Jeremey Grantham. But you likely have never heard of Ben Inker, its head of Asset Allocation. When it comes to betting on the market, Inker has an impressive reputation. And due to GMO’s size, his opinions weigh heavily on market sentiment.

What does Inker think about the stock market today? His recent quarterly letter offers some startling clues. If you’re worried about another market crash, pay close attention.

Here are the facts

Let’s start with the obvious: stocks were a steal back in March. That month, nearly every stock hit multi-month lows. Some hit multi-year lows. It’s easy to say in hindsight, but that market crash was the best buying opportunity in nearly a decade.

“At the March lows, most risk assets appeared to be fair value or cheap, even assuming a moderate hit to fair value from a severe recession,” highlighted Inker. “Over the following six weeks we saw a massive rally in risk assets, particularly equities.”

GMO is famous for its quantitative models that spit out useful information regarding rolling valuations. These models don’t necessarily tell you when to buy or sell, but they provide clues into market sentiment and expected returns.

One of the key figures that GMO shares is its expected long-term annual returns for various asset classes. These returns are derived using rolling valuation multiples. When stocks get pricey, future annual returns are low. When they’re cheap, expected returns rise. After all, investment results are ultimately a function of what you pay.

According to GMO’s models, the spike following the coronavirus market crash resulted in several years of returns jammed into just six weeks.

“We got four to six years of ‘normal’ equity returns in the space of less than two months,” Inker revealed. “Meanwhile, our estimate of the downside risks to the global economy have not notably lessened.”

Expect another market crash

Inker and the rest of the GMO team aren’t necessarily predicting another bear market. But they do stress that uncertainty has seldom been higher.

“Putting firm probabilities on economic scenarios today is extremely difficult,” Inker said. “Economic forecasting is a difficult proposition in the best of times. The fact that the economic outcomes from here significantly depend on the evolution of a pandemic caused by a virus that the world has a total of five months of collective knowledge about makes the task close to impossible.”

This is the basic equation that GMO is using to guide its investment decisions today. Uncertainty has seldom been higher, and valuations are priced for perfection.

This is no time to be betting the farm. That’s why GMO reduced its equity exposure significantly in recent weeks, recycling its capital into lesser-followed asset classes with cheaper valuations.

GMO co-founder Jeremey Grantham summed up fears of another market crash nicely. “We have never lived in a period where the future was so uncertain,” he said. “Yet the market is 10% below its previous high in January when, superficially at least, everything seemed fine in economics and finance.”

If you’re invested in the market, now is the time to buy crash-proof stocks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »